Jack Allen
Stock Analyst at Baird
(0)
# 4873
Out of 5,331 analysts
48
Total ratings
32.35%
Success rate
-26.42%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CARM CARISMA Therapeutics | Downgrades: Neutral | 10 1 | 0.25 | 300% | 3 | Dec 12, 2024 | |
INKT MiNK Therapeutics | Maintains: Outperform | 80 40 | 7.6 | 426.32% | 2 | Nov 15, 2024 | |
VOR Vor Biopharma | Maintains: Outperform | 22 14 | 0.67 | 1989.55% | 3 | Nov 8, 2024 | |
ACLX Arcellx | Maintains: Outperform | 77 106 | 65.5 | 61.83% | 5 | Nov 6, 2024 | |
NTLA Intellia Therapeutic... | Maintains: Neutral | 24 18 | 8.88 | 102.7% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 14.46 | 1144.81% | 9 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | 3.95 | 2937.97% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 2.65 | 201.89% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 38.36 | 35.56% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 30.49 | 175.5% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 8 | 2.56 | 212.5% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 | 1.7 | 605.88% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 0.49 | 920.41% | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | n/a | n/a | 1 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 28 | 1.3 | 2053.85% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 3.62 | 148.62% | 1 | Oct 7, 2021 |